Skip to content
Loading company

Latest annual · FY2011

Millions
Net income
1

Latest quarter · Q3 FY2012

Millions
Total revenues
3
Gross profit
1
Operating income
0
Net income
0
Free cash flow
(1)
Open Financials

China Lithium Technologies Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
Net income$1.3 million$2.4 million-46.7%10-Q 2011-11-21 · proof
Total assets$10.6 million10-Q 2011-11-21 · proof
Total liabilities$2 million10-Q 2011-11-21 · proof
Cash and cash equivalents$2.6 million$2.8 million-4.1%10-Q 2011-11-21 · proof
What was China Lithium Technologies Inc.'s net income in fiscal 2011?
China Lithium Technologies Inc. reported net income of $1.3 million for fiscal 2011 (the year ended Jun 30, 2011), against $2.4 million the year before (-46.7%). Source: the 10-Q filed with the SEC on Nov 21, 2011. SEC
What are China Lithium Technologies Inc.'s total assets?
As of Jun 30, 2011, China Lithium Technologies Inc. reported total assets of $10.6 million. Source: the 10-Q filed with the SEC on Nov 21, 2011. SEC
What are China Lithium Technologies Inc.'s total liabilities?
As of Jun 30, 2011, China Lithium Technologies Inc. reported total liabilities of $2 million. Source: the 10-Q filed with the SEC on Nov 21, 2011. SEC
What are China Lithium Technologies Inc.'s cash and cash equivalents?
As of Jun 30, 2011, China Lithium Technologies Inc. reported cash and cash equivalents of $2.6 million, against $2.8 million a year earlier (-4.1%). Source: the 10-Q filed with the SEC on Nov 21, 2011. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:888719&period_type=annual&limit=5"

Information only, not investment advice.

fmd_03MHX0SNXJDT647Y3CESM2C511 · FinancialMD